We intend to post educational resources and news in Anaesthesia and Intensive care.
Labels
AIRWAY
(12)
ALGORITHMS
(201)
Antimicrobials
(2)
ARDS
(5)
Asthma
(1)
Brain injury
(6)
CARDIAC
(32)
CNS
(42)
COVID19
(6)
CVC
(1)
Death
(1)
DETERIORATING PATIENT
(16)
ELECTROLYTES
(4)
End of Life
(3)
ENDOCRINE
(8)
EVIDENCE BASED PRACTISE
(1)
FEVER
(3)
FLUID AND ELECTROLYTE
(6)
Fungal infections
(3)
GASTROENTEROLOGY
(22)
Haematology
(7)
Head Injury
(3)
HEPARIN
(1)
HEPATIC
(3)
HEPATIC FAILURE
(6)
HME
(2)
ICD
(4)
IHD
(7)
INFECTION
(5)
Insulin
(4)
labour epidural
(1)
LBBB
(2)
METABOLIC
(1)
MH
(1)
MI
(10)
nausea vomiting
(1)
Neurology
(7)
NEWSMAKERS
(1)
NIV
(3)
Nosocomial pneumonia
(3)
NUTRITION
(2)
Obstetrics and Gynaecology
(5)
Organ Donation
(1)
Pacemaker
(1)
Paediatrics
(3)
pancreatitis
(10)
PE
(5)
Percutaneous tracheostomy Video
(1)
perioperative
(3)
Physiology
(6)
PNEUMONIA
(3)
POST-OPERATIVE
(1)
Procedure
(4)
Procedure Video
(6)
pulmonary hypertension
(1)
RADIOLOGY
(8)
Recovery
(1)
Regional
(1)
REGIONAL ANAESTHESIA RESOURCES
(5)
Renal
(22)
RESPIRATORY
(18)
Resuscitation
(5)
RRT
(5)
Safety
(1)
Sedation
(1)
sepsis
(17)
SHOCK
(3)
sleep apnea
(1)
Spinal Anaesthesia
(1)
SPINE
(1)
Toxicology
(12)
Tracheostomy
(3)
Transfusion
(4)
TRAUMA
(10)
Travel
(2)
Vascular
(2)
VENTILATOR
(2)
Tuesday, December 22, 2009
Dopexamine and its role in the protection of hepatosplanchnic and renal perfusion in high-risk surgical and critically ill patients
Dopexamine and its role in the protection of hepatosplanchnic and renal perfusion in high-risk surgical and critically ill patients: "Evidence about the effects of dopexamine was inconsistent and inadequate. There was insufficient evidence to recommend the use of dopexamine for protecting hepatosplanchnic and renal perfusion in high-risk surgical patients, and there was no support for dopexamine for critically ill patients."
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: only a member of this blog may post a comment.